Clay B Siegall

President and CEO

Clay B Siegall (President and CEO) filed 5 Form 4 reports in the trailing twelve months (5 purchases, 0 sales), most often in Immunome, Inc. (IMNM). Across 5 priced purchase filings, the average 21-session return was +28.7% from execution and +24.2% from disclosure (delay-adjusted; derived). The largest single filing was $1000K of IMNM (46,511 sh × $21.50, as filed), executed Dec 18 2025.

Add to watchlist

Return, ttmiAverage return per filing, trailing twelve months

+28.7%

avg across 5 priced filings

Delay-adjustediThe same average, entered at disclosure dates

+24.2%

same 5 filings, from disclosure

Filings, ttm

5 buys · 0 sells

Median delay

execution → disclosure

Volume, ttmiDollar value disclosed in the trailing twelve months

$2.0M

shares × price, as filed

Last traded

Jun 9

Filed Jun 11

Median ADV $31.5M across their filed names

Impact on $10,000 · 12M

$21,576 (+115.8%)

S&P 500 $11,725 (+17.2%) · 98.5 pts ahead

Clay B Siegall S&P 500

Compounded across filings from disclosure dates · past 12 months

Open performance→

Volume by month

Buys $5.1M Sells $0

Shares × price, as filed · by filing month · past 24 months

Sectors filed on

Healthcare 5 filings

Sector per market data · by filing · past 12 months

Most traded names

IMNM

Immunome, Inc. IMNM · 7 buys · 0 sells 7 filings STTK

Shattuck Labs, Inc. STTK · 1 buy · 0 sells 1 filing

Recent filings

STTKPURCHASE Shattuck Labs, Inc. View filing → $250K
62,500 sh × $4.00
Exec Jun 9
Filed Jun 11 · 5:00 PM ET IMNMPURCHASE Immunome, Inc. View filing → $501K
25,450 sh × $19.67
Exec Mar 27
Filed Mar 31 · 7:11 AM ET IMNMPURCHASE Immunome, Inc. View filing → $100K
4,729 sh × $21.15
Exec Dec 30 2025
Filed Dec 30 2025 · 6:47 PM ET IMNMPURCHASE Immunome, Inc. View filing → $149K
7,278 sh × $20.48
Exec Dec 19 2025
Filed Dec 22 2025 · 7:38 AM ET IMNMPURCHASE Immunome, Inc. View filing → $1000K
46,511 sh × $21.50
Exec Dec 18 2025
Filed Dec 18 2025 · 5:03 PM ET IMNMPURCHASE Immunome, Inc. View filing → $999K
137,100 sh × $7.29
Exec Mar 26 2025
Filed Mar 26 2025 · 5:30 PM ET IMNMPURCHASE Immunome, Inc. View filing → $1.2M
150,000 sh × $7.75
Exec Jan 31 2025
Filed Feb 3 2025 · 5:30 PM ET IMNMPURCHASE Immunome, Inc. View filing → $962K
100,000 sh across 2 lots
Exec Nov 21 2024
Filed Nov 25 2024 · 5:30 PM ET